Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's ... - dofaq.co
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's ...
Yahoo Finance - 29 Mar 2024
Most readers would already know that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased by 9.6% over the past...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Yahoo Finance - 05 Nov 2024
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? ...
Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
StockTitan - 06 Nov 2024
Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis ...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
Business Wire - 04 Nov 2024
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Mcdonald Capital Investors Inc. CA
MarketBeat - 07 Nov 2024
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Mcdonald Capital Investors Inc. CA ...
NASDAQ: REGN Lawsuit Against Directors Pending - Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Long Should Contact the Shareholders Foundation
Newswire - 10 Sep 2024
NASDAQ: REGN Lawsuit Against Directors Pending - Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Long Should Contact the Shareholders Foundation ...
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
Yahoo Finance - 01 Nov 2024
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity? ...
The Law Offices of Frank R. Cruz Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
Business Wire - 01 Nov 2024
The Law Offices of Frank R. Cruz Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors ...
Regeneron Reports Third Quarter 2024 Financial and Operating Results
StockTitan - 31 Oct 2024
Regeneron Reports Third Quarter 2024 Financial and Operating Results ...
3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt
MarketBeat - 06 Nov 2024
3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt ...
Regeneron (REGN) Earnings Expected to Grow: Should You Buy?
Yahoo Finance - 24 Oct 2024
Regeneron (REGN) Earnings Expected to Grow: Should You Buy? ...
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $1,000.00 Price Target at Oppenheimer
MarketBeat - 06 Nov 2024
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $1,000.00 Price Target at Oppenheimer ...
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
Yahoo Finance - 01 Nov 2024
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by AIA Group Ltd
MarketBeat - 08 Nov 2024
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by AIA Group Ltd ...
HRMY vs. REGN: Which Stock Is the Better Value Option?
Yahoo Finance - 31 Oct 2024
HRMY vs. REGN: Which Stock Is the Better Value Option? ...
Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
Yahoo Finance - 01 Nov 2024
Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ... ...
Regeneron Pharmaceuticals' (NASDAQ:REGN) earnings growth rate lags the 26% CAGR delivered to shareholders
Yahoo Finance - 22 Oct 2024
Regeneron Pharmaceuticals' (NASDAQ:REGN) earnings growth rate lags the 26% CAGR delivered to shareholders ...
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Yahoo Finance - 31 Oct 2024
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? ...
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
Yahoo Finance - 28 Aug 2024
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More ...
HRMY vs. REGN: Which Stock Is the Better Value Option?
Yahoo Finance - 09 Aug 2024
HRMY vs. REGN: Which Stock Is the Better Value Option? ...